Checkpoint Inhibition Reduces the Threshold for Drug-Specific T-Cell Priming and Increases the Incidence of Sulfasalazine Hypersensitivity. (2022)
Attributed to:
MICA: The North West England MRC Fellowship Scheme in Clinical Pharmacology and Therapeutics
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/toxsci/kfab144
PubMed Identifier: 34850240
Publication URI: http://europepmc.org/abstract/MED/34850240
Type: Journal Article/Review
Volume: 186
Parent Publication: Toxicological sciences : an official journal of the Society of Toxicology
Issue: 1
ISSN: 1096-0929